In a groundbreaking collaboration, Merck Animal Health has forged an agreement with Cambridge Technologies, a leading custom vaccine company headquartered in Worthington, Minnesota, to introduce innovative autogenous poultry vaccines to the U.S. market.
Cambridge Technologies, renowned for its utilization of state-of-the-art molecular diagnostic techniques, is at the forefront of developing tailored vaccine solutions to combat emerging disease challenges in the poultry industry. Through this strategic partnership, Cambridge will leverage its cutting-edge manufacturing capabilities and distribution network, while Merck Animal Health will utilize its extensive customer base to facilitate widespread adoption.
Jim Tate, Executive Director of the Integrated Livestock Business in North America at Merck Animal Health, expressed enthusiasm for the collaboration, stating, “Merck Animal Health is dedicated to enhancing animal health through innovation. This partnership allows us to combine the vast reach of our sales and marketing teams with Cambridge’s diagnostic expertise, offering customized biologics tailored to the unique needs of each flock.”
Cambridge Technologies boasts a USDA-licensed manufacturing facility spanning 37,000 square feet, equipped with advanced fermentation suites to ensure the production of high-quality vaccines.
Jon Mahlberg, Chief Operating Officer of Cambridge Technologies, highlighted the company’s diverse expertise across diagnostics, research and development, quality control, technical support, regulatory affairs, and vaccine production. “Our vaccines are meticulously crafted to address the specific requirements of each customer,” Mahlberg stated, underscoring the company’s commitment to delivering tailored solutions. “Teaming up with Merck Animal Health enables us to further our mission of meeting the evolving demands of poultry producers.”
Preparations for the production of the inaugural vaccine batches are currently underway, marking a significant milestone in the advancement of poultry health management.
